United States (US) headquartered pharmaceutical company Gilead Sciences, is being accused of engaging in inhuman practices of holding on to patents for certain lifesaving drugs, a situation that has condemned millions to new HIV infections and premature deaths. By Kudakwashe Pembere Some of the practices include ever-greening of medicine patents like Truvada which has been in use as a pre-exposure prophylaxis (PrEP) in many countries like Zimbabwe as well as opening the license for the generic production of the hepatitis C drug Harvoni to all low- and middle-income countries. AIDS…
Read MoreGiliead Under Fire For Withholding PrEP Patents
